MAM
TNDM icon

Meeder Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Meeder Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,674
Closed -$269K – 957
2024
Q2 		$269K Buy
+6,674
New +$278K 0.02% 186
2022
Q4 		– Sell
-32
Closed -$2K – 1899
2022
Q3 		$2K Sell
32
-51
-61% -$2.8K ﹤0.01% 1862
2022
Q2 		$5K Buy
83
+33
+66% +$2.71K ﹤0.01% 1668
2022
Q1 		$6K Sell
50
-6
-11% -$700 ﹤0.01% 1751
2021
Q4 		$8K Buy
56
+38
+211% +$5.13K ﹤0.01% 805
2021
Q3 		$2K Buy
+18
New +$1.98K ﹤0.01% 2227
2021
Q1 		– Sell
-2
Closed – – 2457
2020
Q4 		$0 Hold
2
– – ﹤0.01% 2217
2020
Q3 		$0 Sell
2
-4,876
-100% -$512K ﹤0.01% 2376
2020
Q2 		$482K Buy
4,878
+4,323
+779% +$345K 0.03% 370
2020
Q1 		$36K Buy
+555
New +$38.9K ﹤0.01% 1037
2019
Q4 		– Sell
-895
Closed -$52K – 2409
2019
Q3 		$52K Sell
895
-2,184
-71% -$139K ﹤0.01% 1010
2019
Q2 		$199K Sell
3,079
-1,396
-31% -$90.1K 0.01% 581
2019
Q1 		$284K Buy
4,475
+456
+11% +$24K 0.02% 477
2018
Q4 		$152K Buy
4,019
+1,310
+48% +$46.3K 0.01% 563
2018
Q3 		$116K Buy
2,709
+2,575
+1,922% +$89.9K 0.01% 613
2018
Q2 		$2.95K Sell
134
-635
-83% -$7.81K ﹤0.01% 1358
2018
Q1 		$4K Sell
769
-97
-11% -$313 ﹤0.01% 1289
2017
Q4 		$2K Buy
866
+607
+234% +$1.91K ﹤0.01% 1507
2017
Q3 		$2K Buy
259
+168
+185% +$1.06K ﹤0.01% 1481
2017
Q2 		$1K Buy
91
+28
+44% +$259 ﹤0.01% 1555
2017
Q1 		$1K Sell
63
-87
-58% -$1.9K ﹤0.01% 1557
2016
Q4 		$3K Buy
+150
New +$5.77K ﹤0.01% 908

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's TNDM Position: Q3 2024 in Review

Meeder Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 6,674 shares — an estimated $269K sold.

Meeder Asset Management first reported a position in TNDM in Q4 2016 and held it in 22 quarters. The position peaked at $482K in Q2 2020. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Meeder Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Meeder Asset Management sold 6,674 Tandem Diabetes Care shares in Q3 2024, an estimated $269K.
  • Meeder Asset Management first reported a position in Tandem Diabetes Care in Q4 2016 and held it in 22 quarters.
  • Meeder Asset Management's Tandem Diabetes Care position peaked at $482K in Q2 2020.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Meeder Asset Management's 13F filing for Q3 2024, filed 7 Nov 2024.